[New perspectives on anticoagulation for continuous renal replacement therapy: application status and optimization of regional citrate anticoagulation protocol].

Authors

Jiajia Cheng, Ailing Zhao, Jiazheng Sun, Yan Liu

Published in

Zhonghua wei zhong bing ji jiu yi xue. Volume 38. Issue 5. Pages 579-583.

Abstract

At present, the national guidelines recommend regional citrate anticoagulation as the first-line strategy for continuous renal replacement therapy (CRRT) in patients without contraindications, owing to its stable and controllable anticoagulation effect, low bleeding risk, favorable biocompatibility, and relatively few contraindications. However, this strategy still presents clinical drawbacks, including inadequate anticoagulation, higher bleeding risk, and increased medical costs. Based on the clinical practice experience of citrate anticoagulation in CRRT and the existing research evidence, this paper reviews the current application status and core requirements of the regional citrate anticoagulation protocol, summarizes the problems encountered in the implementation of current anticoagulation treatment protocols, and proposes optimization measures. It also explores alternative anticoagulation strategies for special populations and combined anticoagulation regimens, with the aim of providing new insights for improving the safety and cost-effectiveness of CRRT.

PMID:
42427333
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.